Andrew Moin

Insider Reports History

Location
2100 East 54 Th Street North, Sioux Falls, SD
Signature
/s/ Andrew Moin
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew Moin:

Stock Role Class Num Shares Value Price $ Report Date Ownership
SAB Biotherapeutics, Inc. Director Common Stock 2.2M $3.85M $1.75 Sep 29, 2025 Indirect
SAB Biotherapeutics, Inc. Director Series B Convertible Preferred Stock 211K Sep 29, 2025 Indirect
SAB Biotherapeutics, Inc. Director Warrants (right to buy) 114K Jul 22, 2025 Indirect

Insider Reports Filed by Andrew Moin

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SABS SAB Biotherapeutics, Inc. Sep 29, 2025 2 $3.05M 4 Oct 1, 2025 Director
SABS SAB Biotherapeutics, Inc. Jul 22, 2025 3 $0 4 Jul 24, 2025 Director
SABS SAB Biotherapeutics, Inc. Nov 24, 2023 3 -$2.89M 4 Nov 28, 2023 Director
SABS SAB Biotherapeutics, Inc. Nov 10, 2023 1 $13.3M 4/A Nov 15, 2023 Director
SABS SAB Biotherapeutics, Inc. Oct 23, 2023 2 $16.3M 4 Oct 24, 2023 Director
SABS SAB Biotherapeutics, Inc. Oct 2, 2023 0 $0 3 Oct 10, 2023 Director